Related Experiment Video

Updated: Jul 12, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.6K

Loss of early myeloid donor cell engraftment into the central nervous system with nonmyeloablative conditioning

Erin E Nolan1, Willa Durose1, Leyla A Taghizadeh1

  • 1Division of Pediatric Blood and Marrow Transplant, University of Minnesota, Minneapolis, MN.

Blood Advances
|October 23, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

13.3K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.0K

Related Experiment Videos

Last Updated: Jul 12, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.6K
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

13.3K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.0K

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

341
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
341

Articles linked to this work by shared authors, journal, and citation graph.

Prospective Evaluation of Thiotepa Pharmacokinetics in Children and Young Adults Undergoing Allogeneic or Autologous Hematopoietic Cell Transplantation.

Journal of clinical pharmacology·2026

Disease Outcomes in Boys with ABCD1 Variants Identified by Newborn Screening for X-ALD.

medRxiv : the preprint server for health sciences·2026

Promoting donor microglial replacement through augmented conditioning or radiation sensitivity.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Nervonic acid supplementation mitigates disease severity biomarkers in adrenoleukodystrophy.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

Beyond Detection: Comparing State-Based Newborn Screening Methods for Effective Mucopolysaccharidosis I Diagnosis.

International journal of neonatal screening·2026

Use of Brain MRI in Cerebral Adrenoleukodystrophy: International Recommendations for Screening, Monitoring, and Research.

Neurology·2026

National Alliance of Sickle Cell Disease Consensus Recommendations for Gene Therapy Implementation.

Blood advances·2026

Advancing Sickle Cell Disease Care Through Collaboration: the HHS and ASH Registry Leaders' Roundtable Initiative.

Blood advances·2026

Clinical characteristics and outcome of a cohort of CLL patients with BTK T474 gatekeeper mutation.

Blood advances·2026

Prognosis and treatment-related toxicities in Down syndrome acute lymphoblastic leukemia in JCCG ALL-B12.

Blood advances·2026

Loncastuximab and Rituximab in Elderly Unfit/Frail Patients With Previously Untreated Diffuse Large B-Cell Lymphoma.

Blood advances·2026

Persistent Thromboxane Biosynthesis Despite Aspirin Therapy Predicts Preeclampsia.

Blood advances·2026

A Cilia-Centered Nicotinamide Adenine Dinucleotide (NAD+) Signaling Network Regulates Hypothalamic Lysosomal Homeostasis and Metabolic Aging.

Aging cell·2026

EEG-defined differences in functional networks following beta-band transcranial alternating current stimulation in patients with disorders of consciousness: a pilot study.

Journal of neuroengineering and rehabilitation·2026

Network localization of brain structural and functional alterations induced by electroconvulsive therapy for depression.

Translational psychiatry·2026

NR4A2: a next-generation drug target orchestrating dynamic gene regulation and protein interactions.

Drug discovery today·2026

prickle-mediated epilepsy in flies is a brain-derived neurodevelopmental defect.

Journal of neurogenetics·2026

Betaine Attenuates Cuprizone-Induced Cortical Demyelination: The Role of the WNT4/mTOR Signalling Pathway in Regulating Astrogliosis and Synaptic Integrity.

Journal of biochemical and molecular toxicology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us